Effects of Psilocybin on Craving in Nicotine Dependence

Clinical trial registration, sponsored by University of British Columbia, registered 1 Oct 2026.

Phase 2 · not yet recruiting · n = 3

Tags: Registry, Psilocybin, Addiction.

Weekly Science Digest, 20 Jul 2026 to 2 Oct 2026, finding 11: 20 new trials registered

New registrations include psilocybin for methamphetamine use disorder, borderline personality disorder, nicotine craving and premenstrual dysphoric disorder, and a National Institute on Aging trial pairing psilocybin with cognitive training. Results were posted for psilocybin in depression and anxiety in Parkinson's disease.

How much weight it carries: Registrations show what is being attempted, not what was found. (Registry, Plans, not results)

Weekly Science Digest, 26 Sep 2026 to 2 Oct 2026, finding 6: In the clinic

newly registered at UBC: a 25 mg psilocybin dose with repeat fMRI craving scans in nicotine dependence

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Read the original

—
Node—
Statuslive
Throughput—